Open access · CC-BY
via OpenAlex
Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials
Rossana Franzin, Alessandra Stasi, Elena Ranieri, Giuseppe Stefano Netti, Vincenzo Cantaluppi, Loreto Gesualdo, Giovanni Stallone, Giuseppe Castellano
Frontiers in Pharmacology · 2021 · ▲ 39 citations
Genomic instability
Epigenetic alterations
Mitochondrial dysfunction
Cellular senescence
Disabled macroautophagy
Senolytics
Human
Preclinical / animal
Review
Abstract
The biological process of renal aging is characterized by progressive structural and functional deterioration of the kidney leading to end-stage renal disease, requiring renal replacement therapy. Since the discovery of pivotal mechanisms of senescence(definition) such as cell cycle arrest, apoptosis inhibition, and the development of a senescence-associated secretory phenotype (SASP), efforts in the understanding of how senescent cells participate in renal physiological and pathological aging have grown exponentially. This has been encouraged by both preclinical studies in animal models with senescent cell clearance or genetic depletion as well as due to evidence coming from the clinical oncologic experience. This review considers the molecular mechanism and pathways that trigger premature renal aging from mitochondrial dysfunction(definition), epigenetic modifications to autophagy(definition), DNA damage repair (DDR), and the involvement of extracellular vesicles. We also discuss the different pharmaceutical approaches to selectively target senescent cells (namely, senolytics(definition)) or the development of systemic SASP (called senomorphics) in basic models of CKD and clinical trials. Finally, an overview will be provided on the potential opportunities for their use in renal transplantation during ex vivo machine perfusion to improve the quality of the graft.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fphar.2021.630419
- Canonical
- link ↗
- Fetched
- 2026-09-19 MST
Cite this
APA
Franzin, R., Stasi, A., Ranieri, E., Netti, G.S., Cantaluppi, V., Gesualdo, L., Stallone, G., & Castellano, G. (2021). Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials. <em>Frontiers in Pharmacology</em>. https://doi.org/10.3389/fphar.2021.630419
Vancouver
Franzin R, Stasi A, Ranieri E, Netti GS, Cantaluppi V, Gesualdo L, et al. Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials. Frontiers in Pharmacology. 2021. doi:10.3389/fphar.2021.630419.
BibTeX
@article{rossana2021Target,
title = {Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials},
author = {Rossana Franzin and Alessandra Stasi and Elena Ranieri and Giuseppe Stefano Netti and Vincenzo Cantaluppi and Loreto Gesualdo and Giovanni Stallone and Giuseppe Castellano},
journal = {Frontiers in Pharmacology},
year = {2021},
doi = {10.3389/fphar.2021.630419},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2021
Open access · CC-BY
Senescent Cells in Cancer: Wanted or Unwanted Citizens
Advances in Translational Research 2026
Open access · CC-BY
Senotherapeutics: Emerging pharmacological strategies to target cellular senescence
Azerbaijan Journal of Physiology 2025
Open access · CC-BY
Contribution of cellular senescence to kidney disease pathogenesis
Geriatrics Gerontology and Aging 2024
Open access · CC-BY
Moving from an “anti-aging” paradigm toward the concept of “disease-free aging”: the role of senolytics in modern medicine
Frontiers in Cell and Developmental Biology 2020
Open access · CC-BY
Mesenchymal Stem Cell Derived Extracellular Vesicles in Aging
Journal of Clinical Investigation 2022
Open access · CC-BY